Stay updated on AXA4010 Safety in Sickle Cell Disease Clinical Trial
Sign up to get notified when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.

Latest updates to the AXA4010 Safety in Sickle Cell Disease Clinical Trial page
- Check6 days agoChange Detected- Added a government funding notice and operating status information, and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.SummaryDifference5%
- Check14 days agoChange DetectedCore content related to Sickle cell anemia was removed; a new version tag v3.1.0 was added to the page while the previous version tag v3.0.2 was removed.SummaryDifference0.7%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed, with no substantive content changes otherwise.SummaryDifference0.3%
- Check35 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.3%
- Check43 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while also removing several location-related terms and references to safety and sickle cell anemia.SummaryDifference3%
- Check57 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to AXA4010 Safety in Sickle Cell Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.